MS Tech biosensors are designed to support early disease screening and biomarker diagnostics at the point of care. Unlike conventional laboratory-based liquid biopsy analyses, which rely on costly, time-consuming analytical instruments and specialized infrastructure, our technology is aimed to provide immediate diagnostic results helping take timely, data-driven decisions that improve outcomes and quality of life.

Our biotechnology solutions are powered by proprietary High-Frequency Quartz Crystal Microbalance (HF-QCM) sensors. This proven detection platform, widely trusted in security and detection applications worldwide, is now being adapted to meet the unique challenges of medical diagnostics and life sciences. Integrated with IoT capabilities, our biosensors enable seamless data collection and remote decision-making, removing operational delays and streamlining clinical workflows.

Beyond healthcare, MS Tech is actively exploring the use of its biosensors in fields such as agriculture, food quality assurance and environmental monitoring, addressing the growing demand for reliable detection solutions in these critical areas.

As part of the global bio-convergence movement, MS Tech integrates biology, engineering, life sciences and software to develop advanced, multidisciplinary approaches.

Our vision is to make high-quality diagnostics more accessible and empower both medical professionals and individuals to make proactive, informed health decisions.